InvestorLens

CNMD — CONMED CORP

Public company

Sign in to save6 tracked investors reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying CNMD?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence
95
Institutional Conviction
Strong accumulation · 3 buying vs 0 selling last quarter
76
Macro Tailwind
Macro conditions are mixed for this sector
52
Why? — Evidence & Confidence ▾

Of 3 tracked investors who changed their CNMD position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).

Supporting evidence
  • +3 tracked investors added or increased positions last quarter (Howard Marks, Howard Marks, Steve Cohen)
  • +6 tracked investors reported holding CNMD at their latest filing
Contradicting evidence — always shown
  • −13F data is disclosed up to 45 days after quarter end — positions may have changed since
Know the limits
  • · 13F disclosure lag (up to 45 days)
  • · Tracked investors are a sample, not the whole market
  • · Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.

About CONMED CORP (CNMD)

CONMED CORP (CNMD) appears in the most recent 13F filings of 6 tracked institutional investors. The largest disclosed position is held by Howard Marks (Oaktree Capital Management), valued at $35M. Across recent filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CNMD

86
/100
Strong Institutional Accumulation
Added / Increased6
Reduced0
Exited1
BearishBullish
Crowded Trade Score™

How many top investors track CNMD

40
/100
Moderate Interest
6investors

Several tracked investors have exposure.

UndiscoveredCrowded
151015+

CNMD Ownership Composition

How CONMED CORP is held across tracked investor types, based on reported 13F positions.

Dominant Type
Hedge Funds
68% of tracked value
Institutions
6
tracked investors
Total Reported
$58.4M
combined 13F value
Sectors2
  • Hedge Funds68.2%
  • Other31.8%
Hedge Funds(2)
68.2%
Other(4)
31.8%

Tracked investors reporting CNMD

  • Howard MarksMar 31, 2026
    Oaktree Capital Management
    Shares
    36.2M
    Value
    $35.1M
    % Portfolio
    0.54%
  • Ken GriffinMar 31, 2026
    Citadel Advisors
    Shares
    246.9K
    Value
    $8.7M
    % Portfolio
    0.00%
  • Izzy EnglanderMar 31, 2026
    Millennium Management
    Shares
    175.9K
    Value
    $6.2M
    % Portfolio
    0.00%
  • Steve CohenMar 31, 2026
    Point72 Asset Management
    Shares
    134.1K
    Value
    $4.7M
    % Portfolio
    0.01%
  • Paul Tudor JonesDec 31, 2025
    Tudor Investment Corp
    Shares
    82.1K
    Value
    $3.3M
    % Portfolio
    0.01%
  • Ray DalioSep 30, 2025
    Bridgewater Associates
    Shares
    5.9K
    Value
    $279K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold CNMD?
6 tracked institutional investors disclosed a position in CNMD (CONMED CORP) in their most recent 13F filing.
Who is the largest institutional holder of CNMD?
Howard Marks, Oaktree Capital Management, holds the largest disclosed position in CNMD, valued at $35M.
Did institutional ownership of CNMD increase or decrease?
Across recent 13F filings, tracked investors recorded 6 new positions, 0 increased, 0 reduced, and 1 fully exited CNMD.
Where does this CNMD ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.